All News

The Food and Drug Administration has granted accelerated approval to Alunbrig (brigatinib) for metastatic ALK-positive non-small cell lung cancer (NSCLC).

The Food and Drug Administration has approved Rydapt (midostaurin) for acute myeloid leukemia (AML).

Leonard Gomella, M.D., recommends that healthcare providers familiarize themselves with how each novel biomarker should be used and then decide which one to use for a more individualized approach in clinical practice.

It’s the empty place that lies between diagnosis and treatment, but it’s full of life.

The Food and Drug Administration (FDA) has approved Stivarga as a second-line treatment for patients with unresectable hepatocellular carcinoma (HCC) who have previously received Nexavar.

The Food and Drug Administration (FDA) approved a new silicone gel-filled breast implant option, MemoryGel® Xtra, according to Mentor Worldwide LLC, the producer of the implants.

A recent study evaluated the effect of red light on hair growth in women with breast cancer. This low-level light therapy (LLLT), or photobiomodulation therapy, was originally approved by the Food and Drug Administration as a treatment for both men and women with pattern baldness.

We are all so busy, busy, busy with our lives until cancer slows us down, at least temporarily.

Matthew Gubens, M.D., discussed the future of biomarker testing in non-small cell lung cancer.

Shana Wingo, M.D., discussed advancements being made in the field of surgery for patients with gynecologic cancers.

After having bilateral mastectomies, pressure to reconstruct comes from unexpected sources; but I wasn't expecting it to come from my doctor.

A survivor develops a plan for managing anxiety through scan week.

In the world of the Internet, consumers can purchase practically anything they wish for — except a surefire cure for cancer.

A recent study examined common co-morbidities, such as diabetes, heart disease and hypertension, and their effects on ovarian cancer survival.

Cancer has become my unexpected obsession. But there's an upside to that.

A unique story about my service dog and the journey she has taken with me since my cancer diagnosis

When it comes to survival rates for second cancers, younger patients had poorer outcomes than their older counterparts, according to a recent study.

Resiliency is something we really don’t get an opportunity to learn until we are faced with a challenge in life.

All is NOT fair in love and war

While clinical trials are paving the way for new treatments to treat hematologic malignancies, but many patients are apprehensive to participate in them after considering the costs.

How weightlifting helped me through cancer.

Be careful about believing that new drugs could be the "silver bullet" to cure cancer.

We roll the dice every day. When are the odds in our favor?

Just when there's so much to say, you can find yourself walking a verbal tightrope. Let love lead the way.

We need to pace ourselves at the onset for what may be a much longer race than we anticipated.

When I think of living in cancer's shadow, my mind immediately jumps to the dark body that is my constant companion and seems to, paradoxically, grow stronger the brighter the light.

Matthew Yurgelun, M.D., answers questions such as: Which patients with colorectal cancer should recieve molecular testing, and at what point?